Total Payments
$8,189
2024 Payments
$1,783
Companies
58
Transactions
470
Medicare Patients
1,524
Medicare Billing
$146,976
Payment Breakdown by Category
Food & Beverage$8,189 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,189 | 470 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,335 | 62 | $0 (2024) |
| Gilead Sciences, Inc. | $672.30 | 29 | $0 (2024) |
| ViiV Healthcare Company | $514.54 | 24 | $0 (2024) |
| Merck Sharp & Dohme LLC | $448.02 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $430.68 | 21 | $0 (2024) |
| Amgen Inc. | $390.71 | 25 | $0 (2024) |
| PFIZER INC. | $345.60 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $345.36 | 23 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $334.54 | 23 | $0 (2023) |
| Lilly USA, LLC | $332.56 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,783 | 77 | ABBVIE INC. ($549.19) |
| 2023 | $1,495 | 74 | ABBVIE INC. ($339.89) |
| 2022 | $1,111 | 64 | ABBVIE INC. ($125.87) |
| 2021 | $1,008 | 59 | AbbVie Inc. ($220.45) |
| 2020 | $492.15 | 31 | Amarin Pharma Inc. ($73.03) |
| 2019 | $907.19 | 65 | Amgen Inc. ($121.35) |
| 2018 | $524.49 | 36 | Amgen Inc. ($74.53) |
| 2017 | $867.10 | 64 | Merck Sharp & Dohme Corporation ($150.77) |
All Payment Transactions
470 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: HIV | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: PAIN | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Biological | ||||||
| 12/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.83 | General |
| 11/27/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: ETONOGESTREL | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.87 | General |
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Cardio-renal | ||||||
| 10/11/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $136.93 | General |
| Category: Diagnostics | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: HIV | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: VACCINES | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: HIV | ||||||
| 09/19/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $99.94 | General |
| Category: HIV | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Bone Health | ||||||
| 08/16/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Hematology | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: VACCINE | ||||||
| 08/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.39 | General |
| 08/05/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: HIV | ||||||
| 08/02/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 327 | 483 | $65,090 | $33,990 |
| 2022 | 5 | 303 | 500 | $69,740 | $37,227 |
| 2021 | 7 | 431 | 624 | $78,875 | $41,804 |
| 2020 | 7 | 463 | 646 | $74,195 | $33,956 |
Total Patients
1,524
Total Services
2,253
Medicare Billing
$146,976
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 120 | 120 | $25,200 | $14,707 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 184 | $29,440 | $13,921 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 58 | $6,960 | $3,690 | 53.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 98 | $1,960 | $923.44 | 47.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 11 | 12 | $1,200 | $426.12 | 35.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $330.00 | $322.63 | 97.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 250 | $40,000 | $19,327 | 48.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 126 | 126 | $26,460 | $15,759 | 59.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 45 | 98 | $1,960 | $931.50 | 47.5% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 12 | 12 | $900.00 | $819.20 | 91.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $420.00 | $390.61 | 93.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 136 | 136 | $28,560 | $17,367 | 60.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 168 | $26,880 | $13,970 | 52.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 84 | 157 | $18,840 | $7,699 | 40.9% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 16 | 16 | $1,200 | $1,044 | 87.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 47 | 108 | $2,160 | $1,041 | 48.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 27 | 27 | $815.00 | $436.05 | 53.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 12 | 12 | $420.00 | $246.36 | 58.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 120 | 120 | $25,200 | $13,431 | 53.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 94 | 176 | $21,120 | $7,781 | 36.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 121 | $19,360 | $7,141 | 36.9% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 57 | 59 | $4,425 | $3,519 | 79.5% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 44 | 101 | $2,020 | $967.04 | 47.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 55 | 57 | $1,710 | $924.15 | 54.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 12 | 12 | $360.00 | $193.48 | 53.7% |
About Dr. Christopher Gamble, MD
Dr. Christopher Gamble, MD is a Family Medicine healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487609277.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Gamble, MD has received a total of $8,189 in payments from pharmaceutical and medical device companies, with $1,783 received in 2024. These payments were reported across 470 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($8,189).
As a Medicare-enrolled provider, Gamble has provided services to 1,524 Medicare beneficiaries, totaling 2,253 services with total Medicare billing of $146,976. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Salt Lake City, UT
- Active Since 05/23/2006
- Last Updated 06/01/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487609277
Products in Payments
- VRAYLAR (Drug) $790.98
- APRETUDE (Biological) $514.54
- UBRELVY (Drug) $405.64
- FARXIGA (Drug) $180.01
- APTIMA (Device) $170.11
- SHINGRIX (Biological) $167.12
- SOLIQUA 100/33 (Biological) $161.29
- JARDIANCE (Drug) $160.22
- Vascepa (Drug) $151.14
- EVENITY (Biological) $130.93
- ZENPEP (Drug) $127.12
- MOUNJARO (Drug) $126.44
- BELSOMRA (Drug) $118.16
- Prolia (Biological) $108.53
- TRADJENTA (Drug) $105.31
- Veozah (Drug) $103.50
- GARDASIL 9 (Biological) $101.84
- Aimovig (Biological) $100.53
- Descovy (Drug) $99.94
- MYRBETRIQ (Drug) $99.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Salt Lake City
Dr. David Larsen, Md, MD
Family Medicine — Payments: $95,550
Family Medicine $95,550
James Peterson, Md, MD
Family Medicine — Payments: $57,729
Family Medicine $57,729
Mark Cacciamani, Md, MD
Family Medicine — Payments: $42,635
Family Medicine $42,635
Shane Christensen, M.d, M.D
Family Medicine — Payments: $22,787
Family Medicine $22,787
Dr. Derek Muse, M.d, M.D
Family Medicine — Payments: $22,657
Family Medicine $22,657
Jared Probst, Md, MD
Family Medicine — Payments: $18,582
Family Medicine $18,582